MECOM and acute myeloid leukemia: We then determined DEG between EVI1high and EVI1intermediate patient clusters (FDR < 5%) and compared them with DEG from Evi1+ iKMT2A-MLLT3 murine AML originating from TPO- vs PBS-stimulated HSC.